Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01766037 · ClinicalTrials.gov registry record · NA
Pivotal Aspiration Therapy With Adjusted Lifestyle Therapy Study
A NA study of Obesity, sponsored by Aspire Bariatrics.
- Completed
- Registry status
- NA
- Development phase
- 171
- Enrollment target
- 10
- Study locations
NCT01766037: Completed NA study of Obesity, sponsored by Aspire Bariatrics.
NCT01766037 is a NA study of Obesity that has completed, run by Aspire Bariatrics. The registered enrollment target is 171 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (79% lower). The trial reports 10 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01766037, a NA study of Obesity, has completed, sponsored by Aspire Bariatrics.
- COMPLETED
- Registry status
- NA
- Development phase
- 171 participants
- Enrollment target
- 10
- Study locations
Study Summary
This research study is being performed to find out if a new device, AspireAssist Aspiration Therapy System, can help people with obesity to lose weight without causing too many side effects.
Primary Outcome
The first effectiveness co-primary endpoint is the mean percent excess weight loss (%EWL) at 52-weeks. The hypothesis for the first primary effectiveness endpoint is that the difference in the mean percent excess weight loss (%EWL) at 52-weeks for the Aspiration Therapy (AT) group and Control group is at least 10%. Percent EWL is defined as absolute weight loss divided by baseline excess weight and multiplied by 100. Excess weight is determined from ideal body weights based on a BMI=25 kg/m2.
Conditions Studied
Interventions
- DEVICE Aspiration Therapy (AspireAssist)
- BEHAVIORAL Lifestyle Therapy
Study Locations (10)
Massachusetts
- Brigham and Women's Hospital - Boston
- Boston Medical Center - Boston
Pennsylvania
- St. Mary Medical Center - Langhorne
- University of Pennsylvania Center for Weight and Eating Disorders - Philadelphia
California
- Dept VA San Diego Health Care System - San Diego
District of Columbia
- Howard University Center for Wellness and Weight Loss Surgery - Washington D.C.
Illinois
- Northwestern University - Chicago
Minnesota
- Mayo Clinic - Rochester
Missouri
- Washington University School of Medicine - St Louis
New York
- Weill Cornell Medical College - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2012-11-13 |
| Est. Completion | 2019-03-30 |
| Phase | NA |
What the finished NCT01766037 record still lists
NCT01766037 is an interventional study that assigns participants to a tested intervention. The registered 171 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Aspiration Therapy (AspireAssist) is the first listed.
NCT01766037 lists 10 locations in 8 states (Massachusetts, Pennsylvania, California).
Frequently Asked Questions
What is clinical trial NCT01766037 about?
NCT01766037 is a clinical study titled "Pivotal Aspiration Therapy With Adjusted Lifestyle Therapy Study". This research study is being performed to find out if a new device, AspireAssist Aspiration Therapy System, can help people with obesity to lose weight without causing too many side effects.
What is the current status of trial NCT01766037?
This trial is currently completed. It is a NA study. The enrollment target is 171 participants. The study started on 2012-11-13. Estimated completion is 2019-03-30.
What conditions does trial NCT01766037 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT01766037?
The interventions under investigation include: Aspiration Therapy (AspireAssist) (DEVICE), Lifestyle Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01766037?
This trial is sponsored by Aspire Bariatrics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01766037 being conducted?
This trial has 10 study locations across California, District of Columbia, Illinois, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01766037's enrollment target sits among peer trials
171 354th of 1053 higher than 699 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02641145 · 171 participants · NA
Molecular Imaging of Primary Amyloid Cardiomyopathy
- NCT05541029 · 171 participants · NA
Music Listening: A Mechanistic Trial
- NCT05561127 · 171 participants · Phase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
- NCT05592938 · 171 participants · NA
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI